As of 2025-07-06, the EV/EBITDA ratio of Oncternal Therapeutics Inc (ONCT) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONCT's latest enterprise value is -11.52 mil USD. ONCT's TTM EBITDA according to its financial statements is -35.96 mil USD. Dividing these 2 quantities gives us the above ONCT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.1x | 12.8x |
| Forward P/E multiples | 17.1x - 32.0x | 20.6x |
| Fair Price | (203.56) - (154.97) | (198.46) |
| Upside | -38755.6% - -29527.9% | -37786.7% |
| Date | EV/EBITDA |